Isotretinoin in Preventing Skin Cancer

Completed · Not applicable

Conditions studied: Melanoma (Skin), Non-melanomatous Skin Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Isotretinoin may be effective in preventing the development or recurrence of skin cancer. PURPOSE: Clinical trial to study the effectiveness of isotretinoin in preventing or slowing the growth of skin cancer in patients who have xeroderma pigmentosum or basal cell carcinoma.

Key facts

Study ID

NCT00025012

Run by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Starts

1991-06-01

Expected to finish

2004-02-01

Last updated by the study team

2013-06-19

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Intramural Research Program — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.